Skip Navigation



NDT Advance Access published online on January 22, 2009

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn748
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/6/1952    most recent
gfn748v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Triverio, P.-A.
Right arrow Articles by Janssens, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Triverio, P.-A.
Right arrow Articles by Janssens, J.-P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients

Pierre-Alain Triverio1, Pierre-Olivier Bridevaux2, Pascale Roux-Lombard3, Laurent Niksic1, Thierry Rochat2, Pierre-Yves Martin1, Patrick Saudan1 and Jean-Paul Janssens2

1 Division of Nephrology 2 Division of Pulmonary Diseases 3 Division of Immunology and Allergology, Geneva University Hospital, 1211 Geneva 14, Switzerland

Correspondence and offprint requests to: Jean-Paul Janssens, Division of Pulmonary Diseases, Geneva University Hospital, 1211 Geneva 14, Switzerland. Tel: +41-22-372-95-48; Fax: + 41-22-372-99-29; E-mail: jean-paul.janssens{at}hcuge.ch



  Abstract

Background. End stage renal disease increases the risk of reactivating latent tuberculosis (LTBI). Interferon-{gamma} release assays (IGRA) are an alternative to the tuberculin skin test (TST) for detecting LTBI.

Methods. Sixty-two hemodialysis patients (46 male, 16 female, aged 65 ± 15 years) from 3 hemodialysis facilities in the Geneva area were submitted to a TST, 2 IGRA (T-SPOT.TB and QuantiFERON Gold in tube: QFT), a chest radiography, and a questionnaire to record social status, country of birth, history of prior TST, tuberculosis (TB), BCG (Bacillus of Calmette-Guérin vaccine), and any cause of immuno-suppression. LTBI was defined as prior "at risk" contact with a case of contagious TB and/or a chest X-ray suggestive of prior TB infection.

Results. Positivity rate was 19% for TST, 21% for QFT and 29% for T-SPOT-TB; 8% of QFT and 11% of T-SPOT-TB were indeterminate. Agreement between IGRA was fair ({kappa} = 0.60). After adjusting for age and BCG, OR (Odds Ratio) of having a positive QFT was 4.6-fold (p = 0.029) higher in patients with LTBI vs. those without LTBI. In contrast, no association was found between LTBI and having a positive T-SPOT.TB or a positive TST. As expected, there was a strong association between prior BCG vaccination and having a positive TST (OR 5.3, p = 0.017). QFT was the only test with a significant OR of having LTBI (adjusted OR: 4.4; 95%CI: 1.1 – 17.6; p = 0.034). Among 5 patients with definite prior TB, TST and T-SPOT.TB were positive in 1 and QFT, in 2.

Conclusions. In this population, QFT was superior to TST for detecting LTBI, but both IGRAs and TST have important limitations, and are unreliable for screening for LTBI.

Keywords: chronic renal failure; haemodialysis; interferon-gamma release assays; latent tuberculosis infection

Received for publication: 14. 9.08
Accepted in revised form: 12.12.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DTBHome page
Interferon-gamma release assays and TB diagnosis
DTB, June 1, 2009; 47(6): 67 - 70.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.